DE69320844D1 - Antitumorpräparate und Verfahren zur Behandlung - Google Patents

Antitumorpräparate und Verfahren zur Behandlung

Info

Publication number
DE69320844D1
DE69320844D1 DE69320844T DE69320844T DE69320844D1 DE 69320844 D1 DE69320844 D1 DE 69320844D1 DE 69320844 T DE69320844 T DE 69320844T DE 69320844 T DE69320844 T DE 69320844T DE 69320844 D1 DE69320844 D1 DE 69320844D1
Authority
DE
Germany
Prior art keywords
treatment
methods
antitumor preparations
antitumor
preparations
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69320844T
Other languages
English (en)
Other versions
DE69320844T2 (de
Inventor
George Bernard Boder
William Joseph Ehlhardt
Gerald Burr Grindey
John Eldon Toth
John Frederick Worzalla
John Lyle Zimmerman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Application granted granted Critical
Publication of DE69320844D1 publication Critical patent/DE69320844D1/de
Publication of DE69320844T2 publication Critical patent/DE69320844T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Furan Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Undergarments, Swaddling Clothes, Handkerchiefs Or Underwear Materials (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
DE69320844T 1992-02-05 1993-02-01 Antitumorpräparate und Verfahren zur Behandlung Expired - Fee Related DE69320844T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/831,604 US5254582A (en) 1992-02-05 1992-02-05 Antitumor compositions and methods

Publications (2)

Publication Number Publication Date
DE69320844D1 true DE69320844D1 (de) 1998-10-15
DE69320844T2 DE69320844T2 (de) 1999-03-04

Family

ID=25259448

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69320844T Expired - Fee Related DE69320844T2 (de) 1992-02-05 1993-02-01 Antitumorpräparate und Verfahren zur Behandlung

Country Status (25)

Country Link
US (1) US5254582A (de)
EP (1) EP0555036B1 (de)
JP (1) JP3210117B2 (de)
KR (1) KR100246148B1 (de)
CN (1) CN1044239C (de)
AT (1) ATE170853T1 (de)
AU (1) AU658043B2 (de)
BR (1) BR9300469A (de)
CA (1) CA2088719A1 (de)
CY (1) CY2101B1 (de)
CZ (1) CZ282753B6 (de)
DE (1) DE69320844T2 (de)
DK (1) DK0555036T3 (de)
ES (1) ES2121940T3 (de)
FI (1) FI930453A (de)
HU (2) HU213231B (de)
IL (1) IL104574A (de)
MX (1) MX9300558A (de)
MY (1) MY109640A (de)
NO (1) NO302472B1 (de)
NZ (1) NZ245818A (de)
RU (1) RU2072996C1 (de)
SG (1) SG79181A1 (de)
YU (1) YU48915B (de)
ZA (1) ZA93689B (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5116874A (en) * 1985-09-23 1992-05-26 Eli Lilly And Company Anti-tumor method and compounds
US5529999A (en) * 1994-03-04 1996-06-25 Eli Lilly And Company Antitumor compositions and methods of treatment
CN1079096C (zh) * 1996-08-22 2002-02-13 同和药品工业株式会社 用作抗肿瘤剂的芳磺酰基咪唑啉酮衍生物
EP0929540A4 (de) * 1996-10-04 2001-12-12 Lilly Co Eli Antitumor-zusamensetzungen und behandlungsverfahren
AU6967198A (en) * 1997-04-10 1998-10-30 Eli Lilly And Company Diarylsulfonylureas for use in treating secretory diarrhea
US5932407A (en) * 1997-04-30 1999-08-03 Eastman Kodak Company Color photographic element containing oxidized developer-scavenging naphtholic coupler forming wash-out dye
SI1663978T1 (sl) 2003-07-23 2008-02-29 Bayer Pharmaceuticals Corp Fluoro substituirana omega-karboksiaril difenil secnina za zdravljenje ali preprecevanje bolezni instanj
JP5134247B2 (ja) * 2004-09-13 2013-01-30 エーザイ・アール・アンド・ディー・マネジメント株式会社 スルホンアミド含有化合物の血管新生阻害物質との併用
US8772269B2 (en) 2004-09-13 2014-07-08 Eisai R&D Management Co., Ltd. Use of sulfonamide-including compounds in combination with angiogenesis inhibitors
WO2006030941A1 (ja) * 2004-09-13 2006-03-23 Eisai R & D Management Co., Ltd. スルホンアミド含有化合物の血管新生阻害物質との併用
US20100291592A1 (en) 2006-04-20 2010-11-18 Taro Semba Novel marker for sensitivity against sulfonamide compound
CN104941647B (zh) * 2015-06-18 2017-07-04 四川之江高新材料股份有限公司 合成n‑甲基吗啉的方法及所用的负载型催化剂

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3083207A (en) * 1963-03-26 Indolinesulfonylureas
US1208561A (en) * 1914-09-14 1916-12-12 Stephen E Huff Sound-box attachment for phonographs.
US3097242A (en) * 1960-06-29 1963-07-09 Olin Mathieson Hydrindene sulfonylureas
US3102121A (en) * 1961-06-29 1963-08-27 Olin Mathieson Novel cumaransulfonylureas and 2,3-dihydrothionaphthenesulfonylureas
NL295122A (de) * 1962-04-11
US3849110A (en) * 1963-01-07 1974-11-19 Lilly Co Eli Herbicidal method employing aryl-sulfonylureas or salts thereof
US3736122A (en) * 1969-04-10 1973-05-29 C Tung Method of controlling plant growth
AU1862083A (en) * 1982-09-02 1984-03-08 Duphar International Research B.V. Tumor growth inhibitors
CA1208561A (en) * 1984-01-19 1986-07-29 Marius S. Brouwer Pharmaceutical compositions containing benzoylurea compounds
US4845128A (en) * 1984-06-27 1989-07-04 Eli Lilly And Company N([(4-trifluoromethylphenyl)amino]carbonyl)benzene sulfonamides
JPS6163671A (ja) * 1984-09-05 1986-04-01 Shionogi & Co Ltd ２，３−ジヒドロベンゾフラン−５−スルホンアミド誘導体および降圧利尿剤
US5116874A (en) * 1985-09-23 1992-05-26 Eli Lilly And Company Anti-tumor method and compounds
IL80032A (en) * 1985-09-23 1992-07-15 Lilly Co Eli Anti-tumor phenyl-aminocarbonylsulfonamides,their preparation and pharmaceutical compositions containing them
CA1331464C (en) * 1987-05-12 1994-08-16 Eli Lilly And Company Anti-tumor method and compounds
IL98784A0 (en) * 1990-07-17 1992-07-15 Lilly Co Eli Heterocyclyl sulfonamide derivatives,process for their preparation and pharmaceutical compositions containing them
US5169860A (en) * 1992-03-13 1992-12-08 Eli Lilly And Company Antitumor compositions and methods of treatment

Also Published As

Publication number Publication date
NZ245818A (en) 1995-03-28
CZ12093A3 (en) 1993-12-15
DE69320844T2 (de) 1999-03-04
MX9300558A (es) 1993-08-01
EP0555036B1 (de) 1998-09-09
ZA93689B (en) 1994-08-01
EP0555036A2 (de) 1993-08-11
NO930380D0 (no) 1993-02-03
BR9300469A (pt) 1993-08-10
RU2072996C1 (ru) 1997-02-10
IL104574A0 (en) 1993-06-10
CN1044239C (zh) 1999-07-21
KR930017885A (ko) 1993-09-20
SG79181A1 (en) 2001-03-20
HUT63842A (en) 1993-10-28
CN1075961A (zh) 1993-09-08
HU211561A9 (en) 1995-12-28
NO930380L (no) 1993-08-06
US5254582A (en) 1993-10-19
YU5893A (sh) 1996-07-24
HU213231B (en) 1997-03-28
ATE170853T1 (de) 1998-09-15
FI930453A (fi) 1993-08-06
AU3218393A (en) 1993-08-12
KR100246148B1 (ko) 2000-04-01
DK0555036T3 (da) 1999-06-07
AU658043B2 (en) 1995-03-30
MY109640A (en) 1997-03-31
CZ282753B6 (cs) 1997-09-17
EP0555036A3 (en) 1993-11-24
HU9300288D0 (en) 1993-04-28
NO302472B1 (no) 1998-03-09
JP3210117B2 (ja) 2001-09-17
IL104574A (en) 1997-02-18
YU48915B (sh) 2002-11-15
ES2121940T3 (es) 1998-12-16
CA2088719A1 (en) 1993-08-06
JPH05306277A (ja) 1993-11-19
FI930453A0 (fi) 1993-02-02
CY2101B1 (en) 2002-04-05

Similar Documents

Publication Publication Date Title
DE69736441D1 (de) Pharmazeutische zusammensetzung zur behandlung von neurologischen und neuropsychiatrischen erkrankungen
NO304884B1 (no) 9-[(substituerte glycyl)amido]-6-demetyl-6-deoksotetracykliner, og medisinske preparater derav
GEP20012413B (en) Novel Substituted Cyclic Amino Acids as Pharmaceutical Agents
BG104561A (en) Aryl fused azapolycyclic compounds
TR199901132T2 (xx) N-(aril/heteoaril) amino asit t�revleri, bunlar� i�eren farmas�tik bile�imler ve b�yle bile�ikler kullan�larak �-amiloid peptidinin sal�nmas�n� ve/veya sentezini inhibe etmek i�in y�ntemler.
ATE170853T1 (de) Antitumorpräparate und verfahren zur behandlung
DE19580261D2 (de) Pharmazeutische Zubereitungen und Arzneistoffe zur Prävention und Behandlung endothelialer Dysfunktion
FR2740134B1 (fr) Derives d'amines cycliques d'aryl-piperazines, leur preparation et les compositions pharmaceutiques les contenant
RU93004535A (ru) Соединения, способ получения и фармацевтическая композиция на их основе
MX9707642A (es) Uso de 2-oxoindol-1-carboxamidas 3-sustituidas y sus sales de base farmaceuticamente aceptables para preparar composiciones para el tratamiento y prevencion de la enfermedad de alzheimer en mamiferos, incluyendo a humanos.
TR199900480T2 (xx) Kristalin farmas�tik �r�n.
RU95105249A (ru) Гидрохлорид ng монометил-l-аргинина, способы его получения, способ получения фармацевтического препарата и способ лечения
DE69327074D1 (de) Substituierte 1,2,4-Triazine-3,5-Dion Derivate und diese enthaltende Arzneimittel, insbesondere zur Behandlung von Coccidiose
GR3035004T3 (en) Method and composition for the treatment of herpes related disorders.
TH9193B (th) สารผสมต่อต้านเนื้องอกและวิธีของการรักษา
TH13149EX (th) สารผสมต่อต้านเนื้องอกและวิธีของการรักษา
TH13149A (th) สารผสมต่อต้านเนื้องอกและวิธีของการรักษา
IT1282951B1 (it) Formulazioni farmaceutiche gastroresistenti contenenti colostro e uso del colostro per il trattamento dell'insonnia
ITMI951410A0 (it) Utilizzo di sequenze di endorfina per la preparazione di un medicamento immunosoppressore privo di attivita' oppiacea

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee